Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
12/2004
12/02/2004WO2004103994A1 Furazanobenzimidazoles
12/02/2004WO2004103976A2 Method for synthesising heterocyclic compounds from thiourea derivatives
12/02/2004WO2004103973A1 Phenyl quinolines and their use as estrogen receptor modulators
12/02/2004WO2004103279A2 3-(2-amino-1-azacyclyl)-5-aryl-1,2,4-oxadiazoles as s1p receptor agonists
12/02/2004WO2004076413A3 Phenyl- and pyridylpiperidine-derivatives as modulators of glucose metabolism
12/02/2004WO2004072031A3 Phenylacetamides and their use as glucokinase modulators
12/02/2004WO2004071389A3 Non-steroidal infalmmation inhibitors
12/02/2004US20040242895 herbicides
12/02/2004US20040242871 Nitric oxide synthease inhibitors; antiinflamamtory agents; analgesics; inflamamtory bowel disorders; antiarthritic agents;
12/02/2004US20040242672 Pyrrolidine derivatives
12/02/2004US20040242666 Isoxazole and isothiazole compounds for the treatment of neurodegenerative disorders
12/02/2004US20040242660 Combinations of oxazolidinones with other active ingredients for the prophylaxis and/or treatment of thromboembolic disorders
12/02/2004US20040242659 Heterocyclic compounds, oxazole derivatives, process for preparation of the same and use thereof
12/02/2004US20040242645 Pesticides
12/02/2004US20040242636 Enzyme inhibitors as antiinflammatory ageents for psoriasis, obesity
12/02/2004US20040242633 Compound used to lower cholesterol, reduce weight for dietetics, antidepressants and antidiabetic agents
12/02/2004US20040242631 PI-3 kinase inhibitor prodrugs
12/02/2004US20040242627 2-Iminoimidazole derivatives (1)
12/02/2004US20040242615 enhancing the expression of apoAI; prevention or therapy of dislipidemia
12/02/2004US20040242609 Therapy for eating disorders, sexual disorders, psychological disorders
12/02/2004US20040242603 Quinoline derivative and quinazoline derivative inhibiting self-phosphorylation of hepatocytus proliferator receptor and medicinal composition containing the same
12/02/2004US20040242591 phenyloxazolidinones derivatives that exhibit significantly greater antibacterial activity, than available with the present compounds against multiply resistant gram positive pathogens
12/02/2004US20040242578 Pyrimidineamines as angiogenesis modulators
12/02/2004US20040242577 N-methyl 2-morpholine-4-carbonyl or sulfonyl substituted; for example: 2-{[4-(3,4-dichlorophenoxy)piperidin-1-yl]methyl}morpholine; useful for treating asthma and/or rhinitis
12/02/2004US20040242575 for use with various disorders including sleep disorders; depression; cardiovascular disorders; pain; neurodegenerative disorders; psychiatric disorders etc.
12/02/2004US20040242574 Anticancer agents; antiarthritic agents
12/02/2004US20040242573 Novel compounds
12/02/2004US20040242560 Process for synthesizing heterocyclic compounds
12/02/2004US20040242554 Eating disorders; cognition activators; psychological disorders; anxiolytic agents; sexual disorders; incontinence; antidepressants
12/02/2004US20040241781 Using benzodiazepine derivatives to treat and prevent defects in programed cell death, autoimmune, inflammatory and cell proliferative diseases
12/02/2004DE10308353A1 Diarylcycloalkylderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Diarylcycloalkylderivate, processes for their preparation and their use as medicaments
12/02/2004CA2526646A1 Method for synthesising heterocyclic compounds from thiourea derivatives
12/02/2004CA2525292A1 Phenyl quinolines and their use as estrogenic agents
12/02/2004CA2524867A1 3-(2-amino-1-azacyclyl)-5-aryl-1,2,4-oxadiazoles as s1p receptor agonists
12/01/2004EP1481976A1 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient
12/01/2004EP1481975A1 Inhibitors of farnesyl protein transferase
12/01/2004EP1481972A1 Cyclic compound, process for producing the same, and pest control agent
12/01/2004EP1481970A1 Novel herbicides
12/01/2004EP1481966A1 Novel arylamidine derivative or salt thereof
12/01/2004EP1481965A1 Aromatic amino acid derivatives and medicinal compositions
12/01/2004EP1480975A2 Chemical compounds
12/01/2004EP1480974A1 Heterocyclylmethylpiperidines and -piperazines possessing affinity at 5ht-1 type receptors
12/01/2004EP1480973A1 1,4-disubstituted benzofused cycloalkyl urea compounds useful in treating cytokine mediated diseases
12/01/2004EP1480972A2 Compounds possessing affinity at 5ht1-type receptors and use thereof in therapy of cns disorders
12/01/2004EP1480959A1 Piperazine derivatives as anti-inflammatory agents
12/01/2004EP1480958A1 Uracil-thioether
12/01/2004EP1480957A1 Hppars activators
12/01/2004EP1480951A1 Synthesis of indole thiazole compounds as ligands for the ah receptor
12/01/2004EP1480643A1 Use of epothilones in the treatment of brain diseases associated with proliferative processes
12/01/2004EP1480642A1 Peroxisome proliferator activated receptor modulators
12/01/2004EP1480640A1 Peroxisome proliferator activated receptor modulators
12/01/2004EP1181280B1 Substituted benzoyl ketones, methods for producing them and their use as herbicides
12/01/2004EP1104407B1 Compounds as selective agonists at alpha 2b or 2b/2c adrenergic receptors
12/01/2004EP0977745B1 Thioaryl sulfonamide hydroxamic acid compounds
12/01/2004EP0886637B1 Inhibitors of microsomal triglyceride transfer protein and method
12/01/2004CN1551876A 6-aryl-4-aminopicolinates and their use as herbicides
12/01/2004CN1551769A Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
12/01/2004CN1551761A Inhibitors of acyl glucosaminyl inositol amidase and methods of use
12/01/2004CN1550491A Novel delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides
12/01/2004CN1177847C Oxazolidines compounds as 5-HT2A-antagonists
12/01/2004CN1177846C Oxa(thia) diazolylpyridazinone derivative and its preparing process and application
12/01/2004CN1177845C Method for producing 7-(phrazole-3-yl) benzoxazoles
12/01/2004CN1177821C Matrix metalloprotease inhibitors
11/2004
11/30/2004US6825365 Intermediates for the hemisynthesis of taxanes and preparation processes therefor
11/30/2004US6825228 To treat infections by gram-positive bacteria, in particular drug- resistant strains
11/30/2004US6825225 Bicyclic isoxazolinones as antibacterial agents
11/30/2004US6825224 Prodrugs of carbamate inhibitors of IMPDH
11/30/2004US6825222 Modulators of peroxisome proliferator activated receptors
11/30/2004US6825219 Substituted benzimidazole compounds
11/30/2004US6825215 1,1-disubstituted cyclic inhibitors of matrix metalloproteases and TNF-α
11/30/2004US6825192 Non-n-methyl-d-aspartate (non- nmda) excitatory amino acid receptor antagonistic action, for example 2-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (ampa) receptor antagonistic action
11/30/2004US6825190 Protein kinase inhibitors and uses thereof
11/30/2004US6825185 Improving the cardiovascular profile of a cox-2 selective inhibitor by administering with 3-hydroxy-3- methylglutaryl coenzyme a, an antiplatelet agent, a thrombin inhibitor or a thromboxane inhibitor
11/25/2004WO2004101559A1 Fused bicyclic-substituted amines as histamine-3 receptor ligands
11/25/2004WO2004101557A1 Heterocyclic compounds
11/25/2004WO2004101556A1 INDAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS
11/25/2004WO2004101555A1 TRIAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS
11/25/2004WO2004101554A1 New indole derivatives as factor xa inhibitors
11/25/2004WO2004101553A1 BENZIMIDAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS
11/25/2004WO2004101552A1 Oxazolidinone derivatives as antibacterial agents
11/25/2004WO2004101546A1 Piperazine derivatives and their use for the treatment of neurological and psychiatric diseases
11/25/2004WO2004101544A1 Benzyl sulfonamide derivatives as androgen receptor antagonists
11/25/2004WO2004101537A1 Metalloproteinase inhibitors
11/25/2004WO2004101533A1 1, 3, 4-benzotriazepin-2-one salts and their use as cck receptor ligands
11/25/2004WO2004101528A2 Isoquinoline derivatives and their use as gfat inhibitors
11/25/2004WO2004101518A1 4-arylsulphonylpiperidine derivatives for antagonism of the 5-ht2a receptor
11/25/2004WO2004101517A1 Carbazole derivative, organic semiconductor device, light-emitting device, and electronic device
11/25/2004WO2004101512A2 Naphthyridine integrase inhibitors
11/25/2004WO2004100998A2 Compositions and methods for non-invasive imaging of soluble beta-amyloid
11/25/2004WO2004100960A2 Anti-inflammatory phosphonate compounds
11/25/2004WO2004100958A1 2, 3, 4, 5-tetrahydrobenzo[f][1, 4]oxazepine-5-carboxylic acid amide derivatives as gamma-secretase inhibitors for the treatment of alzheimer’s disease
11/25/2004WO2004100946A1 1- (2h-pyrazol -3-yl) -3yl) {4-`1- (benzoyl) -piperidin-4-ylmethyl!-phenyl}-urea derivatives and related compounds as inhbitors of p38 kinase and/or tnf inhibitors for the treatment of imflammations
11/25/2004WO2004100881A2 Preparation and use of aryl alkyl acid derivatives for the treatment of obesity
11/25/2004WO2004100873A2 Compounds, compositions, and methods
11/25/2004WO2004089942A3 Benzimidazolidinone derivatives as muscarinic agents
11/25/2004WO2004083174A3 Sulfonyl-amidino containing and tetrahydropyrimidino containing compounds as factor xa inhibitors
11/25/2004WO2004043379A3 Chemical compounds
11/25/2004WO2004027378A3 Luminescence-based methods and probes for measuring cytochrome p450 activity
11/25/2004US20040236151 Process to produce enantiomerically enriched 1-aryl-and 1-heteroaryl-2-aminoethanols
11/25/2004US20040236114 1-[(hetero)aryloxy- or -thio-hydroxyalkyl]-substituted imidazole-4-carboxamides, e.g., 1-(5-(1,1'-biphenyl-3-yloxy)-2-hydroxy-3-pentyl]imidazole-4-carboxamide; treating rheumatoid arthritis, rheumatoid spondylitis, osteoarthritis, gouty arthritis, sunburn, eczema, conjunctivitis, asthma, & bronchitis